The High-Affinity Interaction between ORC and DNA that Is Required for Replication Licensing Is Inhibited by 2-Arylquinolin-4-Amines-Reference-Cited by-同舟云学术

The High-Affinity Interaction between ORC and DNA that Is Required for Replication Licensing Is Inhibited by 2-Arylquinolin-4-Amines

Published:2017-08 Issue:8 Volume:24 Page:981-992.e4
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Gardner Nicola J.,Gillespie Peter J.,Carrington Jamie T.,Shanks Emma J.,McElroy Stuart P.,Haagensen Emma J.,Frearson Julie A.,Woodland Andrew,Blow J. Julian

Funder

CR-UK

Wellcome Trust

MRC-DPFS

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference66 articles.

1. Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells;Arias;Genes Dev.,2007

2. ATP-dependent recognition of eukaryotic origins of DNA replication by a multiprotein complex;Bell;Nature,1992

3. Preventing re-replication of DNA in a single cell cycle: evidence for a replication licensing factor;Blow;J. Cell Biol.,1993

4. Preventing re-replication of chromosomal DNA;Blow;Nat. Rev. Mol. Cell Biol.,2005

5. A model for DNA replication showing how dormant origins safeguard against replication fork failure;Blow;EMBO Rep.,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A high-throughput screening identifies MCM chromatin loading inhibitors targeting cells with increased replication origins;iScience;2024-08

2. Reconstitution of human DNA licensing and the structural and functional analysis of key intermediates;2024-04-11

3. Inhibition of Replication Origins and ATR Synergistically Activates the Innate Immune System in Cancer Cells;2023-09-08

4. Linking replication stress with replication dynamics in Vicia faba root meristem cells;2023-07-24

5. Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma;Cancers;2022-07-22